Taking glutathione — as a pill, patch, or especially an IV 'drip' — safely and reliably whitens/brightens skin and reverses aging. This is marketed heavily on TikTok and TikTok Shop as glow/anti-aging/skin-whitening content and product sales, with hundreds of millions of views on related hashtags, and frequently positions IV infusions specifically as the fast, superior, 'inside-out' route to results.
Oral glutathione has a real but modest, non-permanent skin-lightening effect in sun-exposed skin at 250-600mg/day over weeks to months (Arjinpathana & Asawanonda 2012; Weschawalit et al. 2017; Sarkar et al. 2024; Dilokthornsakul et al. 2019) — real, but far short of marketing's 'glow transformation' framing. A pooled meta-analysis further found glutathione supplementation does not reliably even raise measured blood glutathione levels (Mangkalopakorn et al. 2024), undercutting the mechanism the marketing assumes. IV glutathione specifically has no controlled evidence of efficacy (the only placebo-controlled IV RCT found no significant benefit over placebo) and carries documented safety risk: deranged liver enzymes and anaphylaxis in that same trial, individual case reports of Stevens-Johnson syndrome and systemic inflammatory response syndrome with acute liver/kidney injury, and — as of August 2026 — two separate US pharmacy recalls of compounded glutathione injections for bacterial endotoxin contamination, the same failure mode the FDA already warned about in 2019.
The gap is not just 'works less than advertised' — it is a route-of-administration inversion. The form the evidence actually supports best (oral, modest effect) is the one marketing treats as the weak, slow option, while the form marketing pushes hardest as the 'real' fast-acting treatment (IV drips) is the one with no proven efficacy and the only documented pattern of serious harm, including real 2026 FDA recalls for bacterial contamination.